Strum Jay 4
4 · G1 Therapeutics, Inc. · Filed Aug 31, 2018
Insider Transaction Report
Form 4
Strum Jay
Chief Scientific Officer
Transactions
- Sale
Comomon Stock
2018-08-29$61.00/sh−200$12,200→ 53,569 total - Sale
Comomon Stock
2018-08-29$59.10/sh−3,500$206,850→ 54,469 total - Sale
Comomon Stock
2018-08-29$58.40/sh−600$35,042→ 57,969 total - Sale
Comomon Stock
2018-08-29$60.00/sh−700$42,003→ 53,769 total - Sale
Comomon Stock
2018-08-30$59.27/sh−500$29,633→ 53,069 total - Sale
Comomon Stock
2018-08-30$60.05/sh−4,500$270,243→ 48,569 total
Footnotes (6)
- [F1]The price represents the weighted average price with a low of $57.79 and a high of $58.695. The Reporting Person undertakes to provide G1 Therapeutics, Inc., any security holder of G1 Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 1 through 6.
- [F2]The price represents the weighted average price with a low of $58.80 and a high of $59.72.
- [F3]The price represents the weighted average price with a low of $59.88 and a high of $60.14.
- [F4]The price represents the weighted average price with a low of $60.95 and a high of $61.05.
- [F5]The price represents the weighted average price with a low of $58.65 and a high of $59.58.
- [F6]The price represents the weighted average price with a low of $59.68 and a high of $60.33.